We came across a bullish thesis on Intuitive Surgical, Inc. on Uncle Stock Notes’s Substack. In this article, we will ...

Intuitive Machines stock is still a "Buy" amid a 72% gain and reaching out price target. Here's what investors need to know.

Intuitive Surgical's 2025 earnings were strong, and the future remains bright, with valuation as the only big concern for investors.

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

Intuitive Machines has agreed to acquire Lanteris Space Systems in a pending $800 million deal that would expand its role into vertically integrated space infrastructure. The company has also been ...

Houston’s lunar technology specialist reported a recent insider sale amid ongoing efforts to expand its footprint in space exploration.

This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.

Intuitive Surgical has received FDA clearance for cardiac procedures using the da Vinci 5 surgical robot, according to a Jan. 26 report from Mass Device. The new cardiac clearances cover mitral valve ...

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model.

Fourth quarter 2025 GAAP net income attributable to Intuitive was $795 million, or $2.21 per diluted share, compared with $686 million, or $1.88 per diluted share, in the fourth quarter of 2024.